264 related articles for article (PubMed ID: 20508983)
21. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
Olson JE; Ingle JN; Ma CX; Pelleymounter LL; Schaid DJ; Pankratz VS; Vierkant RA; Fredericksen ZS; Wu Y; Couch FJ; Vachon CM; Sellers TA; Weinshilboum RM
Breast Cancer Res Treat; 2007 Apr; 102(2):237-47. PubMed ID: 17004113
[TBL] [Abstract][Full Text] [Related]
23. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
24. Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population.
Lesueur F; Song H; Ahmed S; Luccarini C; Jordan C; Luben R; Easton DF; Dunning AM; Pharoah PD; Ponder BA
Br J Cancer; 2006 Jun; 94(12):1921-6. PubMed ID: 16685266
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
Purrington KS; Slettedahl S; Bolla MK; Michailidou K; Czene K; Nevanlinna H; Bojesen SE; Andrulis IL; Cox A; Hall P; Carpenter J; Yannoukakos D; Haiman CA; Fasching PA; Mannermaa A; Winqvist R; Brenner H; Lindblom A; Chenevix-Trench G; Benitez J; Swerdlow A; Kristensen V; Guénel P; Meindl A; Darabi H; Eriksson M; Fagerholm R; Aittomäki K; Blomqvist C; Nordestgaard BG; Nielsen SF; Flyger H; Wang X; Olswold C; Olson JE; Mulligan AM; Knight JA; Tchatchou S; Reed MW; Cross SS; Liu J; Li J; Humphreys K; Clarke C; Scott R; ; Fostira F; Fountzilas G; Konstantopoulou I; Henderson BE; Schumacher F; Le Marchand L; Ekici AB; Hartmann A; Beckmann MW; Hartikainen JM; Kosma VM; Kataja V; Jukkola-Vuorinen A; Pylkäs K; Kauppila S; Dieffenbach AK; Stegmaier C; Arndt V; Margolin S; ; ; Balleine R; Arias Perez JI; Pilar Zamora M; Menéndez P; Ashworth A; Jones M; Orr N; Arveux P; Kerbrat P; Truong T; Bugert P; Toland AE; Ambrosone CB; Labrèche F; Goldberg MS; Dumont M; Ziogas A; Lee E; Dite GS; Apicella C; Southey MC; Long J; Shrubsole M; Deming-Halverson S; Ficarazzi F; Barile M; Peterlongo P; Durda K; Jaworska-Bieniek K; Tollenaar RA; Seynaeve C; ; Brüning T; Ko YD; Van Deurzen CH; Martens JW; Kriege M; Figueroa JD; Chanock SJ; Lissowska J; Tomlinson I; Kerin MJ; Miller N; Schneeweiss A; Tapper WJ; Gerty SM; Durcan L; Mclean C; Milne RL; Baglietto L; dos Santos Silva I; Fletcher O; Johnson N; Van'T Veer LJ; Cornelissen S; Försti A; Torres D; Rüdiger T; Rudolph A; Flesch-Janys D; Nickels S; Weltens C; Floris G; Moisse M; Dennis J; Wang Q; Dunning AM; Shah M; Brown J; Simard J; Anton-Culver H; Neuhausen SL; Hopper JL; Bogdanova N; Dörk T; Zheng W; Radice P; Jakubowska A; Lubinski J; Devillee P; Brauch H; Hooning M; García-Closas M; Sawyer E; Burwinkel B; Marmee F; Eccles DM; Giles GG; Peto J; Schmidt M; Broeks A; Hamann U; Chang-Claude J; Lambrechts D; Pharoah PD; Easton D; Pankratz VS; Slager S; Vachon CM; Couch FJ
Hum Mol Genet; 2014 Nov; 23(22):6034-46. PubMed ID: 24927736
[TBL] [Abstract][Full Text] [Related]
26. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
[TBL] [Abstract][Full Text] [Related]
27. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Milne RL; Ribas G; González-Neira A; Fagerholm R; Salas A; González E; Dopazo J; Nevanlinna H; Robledo M; Benítez J
Cancer Res; 2006 Oct; 66(19):9420-7. PubMed ID: 17018596
[TBL] [Abstract][Full Text] [Related]
28. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
Wang X; Goode EL; Fredericksen ZS; Vierkant RA; Pankratz VS; Liu-Mares W; Rider DN; Vachon CM; Cerhan JR; Olson JE; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2101-8. PubMed ID: 18708403
[TBL] [Abstract][Full Text] [Related]
29. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
30. Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.
Einarsdóttir K; Humphreys K; Bonnard C; Palmgren J; Iles MM; Sjölander A; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
PLoS Med; 2006 Jun; 3(6):e168. PubMed ID: 16671833
[TBL] [Abstract][Full Text] [Related]
31. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.
Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Khuhaprema T; Yoshida T
Breast Cancer Res Treat; 2010 Oct; 123(3):885-93. PubMed ID: 20180013
[TBL] [Abstract][Full Text] [Related]
33. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
34. Association between single nucleotide polymorphisms of DNA damage response pathway genes and increased risk in breast cancer.
Mehmood A; Kayani MA; Ahmed MW; Nisar A; Mahjabeen I
Future Oncol; 2020 Sep; 16(26):1977-1995. PubMed ID: 32597209
[No Abstract] [Full Text] [Related]
35. Pathway-Affecting Single Nucleotide Polymorphisms (SNPs) in RPS6KA1 and MBIP Genes are Associated with Breast Cancer Risk.
Shareefi G; Turkistani AN; Alsayyah A; Kussaibi H; Abdel Hadi M; Alkharsah KR
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2163-2168. PubMed ID: 32711446
[TBL] [Abstract][Full Text] [Related]
36. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
[TBL] [Abstract][Full Text] [Related]
37. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
Rotunno M; Yu K; Lubin JH; Consonni D; Pesatori AC; Goldstein AM; Goldin LR; Wacholder S; Welch R; Burdette L; Chanock SJ; Bertazzi PA; Tucker MA; Caporaso NE; Chatterjee N; Bergen AW; Landi MT
PLoS One; 2009 May; 4(5):e5652. PubMed ID: 19479063
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in five genes important in telomere biology and risk for breast cancer.
Savage SA; Chanock SJ; Lissowska J; Brinton LA; Richesson D; Peplonska B; Bardin-Mikolajczak A; Zatonski W; Szeszenia-Dabrowska N; Garcia-Closas M
Br J Cancer; 2007 Sep; 97(6):832-6. PubMed ID: 17848914
[TBL] [Abstract][Full Text] [Related]
39. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
40. Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.
Couch FJ; Wang X; Bamlet WR; de Andrade M; Petersen GM; McWilliams RR
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):251-7. PubMed ID: 20056645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
